# VICTOZA
> **NDA022341** · New Drug Application · Sponsor: NOVO NORDISK INC · Approved 2010-01-25
## Drug
- **FDA Application Number:** NDA022341
- **Application type:** New Drug Application
- **Brand name:** VICTOZA
- **Generic name:** LIRAGLUTIDE
- **Active ingredients:** LIRAGLUTIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** NOVO NORDISK INC
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2010-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022341)
---
*AI Analytics · CC0 1.0*